Drug ID: | NPD4751 |
Drug Name: | |
Molecular Formula: | C21H30O3 |
Canonical SMILES: | C#C[C@]1(O)CC[C@@H]2[C@]1(C)CC[C@H]1[C@H]2[C@@H](O)C=C2[C@]1(C)CC[C@@H](C2)O |
Standard InCHI: | InChI=1S/C21H30O3/c1-4-21(24)10-7-16-18-15(6-9-20(16,21)3)19(2)8-5-14(22)11-13(19)12-17(18)23/h1,12,14-18,22-24H,5-11H2,2-3H3/t14-,15-,16-,17-,18+,19-,20-,21-/m0/s1 |
Standard InCHIKey: | JJKOQZHWYLMASZ-FJWDNACWSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL001659 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 16739648 |
ChEBI | |
CAS Number |
Molecular Weight | 330.22 |
ALogP | 0.1062 |
MLogP | 3.44 |
XLogP | 2.055 |
HDA | 3 |
HBD | 3 |
Rotatable Bonds | 5 |
TPSA | 60.69 |
RO5 Violation | 0 |